Carnitine palmitoyltransferase 2 (CPT2) was decreased in CRC, and CPT2 downregulation could trigger stemness and oxaliplatin resistance in CRC via the activation of ROS/Wnt/β-catenin-induced glycolytic metabolism [181]. Here, CPT2 is linked to colorectal carcinoma.